| scholarly article | Q13442814 |
| P50 | author | Servet Altay | Q48883139 |
| P2093 | author name string | Mehmet Eren | |
| Günay Can | |||
| Ayça Türer | |||
| Hatice Betül Erer | |||
| Tuğba Kemaloğlu Öz | |||
| Hüseyin Altuğ Çakmak | |||
| Fatma Özpamuk Karadeniz | |||
| İbrahim Keleş | |||
| Gülen Feyzan Kılıç | |||
| P2860 | cites work | Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease | Q73088403 |
| Prognostic value of pentraxin 3 in patients with chronic heart failure | Q80111779 | ||
| Long-term prognostic value of elevated pentraxin 3 in patients undergoing primary angioplasty for ST-elevation myocardial infarction | Q85348046 | ||
| Correlation of serum high-sensitivity C-reactive protein and interleukin-6 in patients with acute coronary syndrome | Q87410123 | ||
| TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation : An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy | Q22241926 | ||
| PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans | Q33912738 | ||
| Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction | Q34056876 | ||
| Production of the long pentraxin PTX3 in advanced atherosclerotic plaques | Q34128059 | ||
| Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study | Q34150807 | ||
| Third universal definition of myocardial infarction | Q34295914 | ||
| Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction | Q34357988 | ||
| Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites | Q34380249 | ||
| Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility | Q34403569 | ||
| Characterization of the promoter for the human long pentraxin PTX3. Role of NF-kappaB in tumor necrosis factor-alpha and interleukin-1beta regulation | Q34420055 | ||
| ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 199 | Q35562839 | ||
| The long pentraxin PTX3 in vascular pathology | Q36615475 | ||
| Long pentraxin 3: experimental and clinical relevance in cardiovascular diseases | Q36830914 | ||
| Pentraxins and atherosclerosis: the role of PTX3. | Q37827889 | ||
| Inflammatory markers and cardiometabolic diseases | Q38535519 | ||
| Usefulness of Highly Sensitive Troponin as a Predictor of Short-Term Outcome in Patients With Diabetes Mellitus and Stable Coronary Artery Disease (from the ARTEMIS Study). | Q40995578 | ||
| Value of pentraxin-3 and galectin-3 in acute coronary syndrome: a short-term prospective cohort study | Q41151739 | ||
| Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). | Q47240592 | ||
| Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarction | Q48395268 | ||
| Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions. | Q53502969 | ||
| Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. | Q53510759 | ||
| The ENACT study: a pan-European survey of acute coronary syndromes | Q57243553 | ||
| P433 | issue | 3 | |
| P921 | main subject | acute myocardial infarction | Q18558122 |
| P304 | page(s) | 202-209 | |
| P577 | publication date | 2016-08-02 | |
| P1433 | published in | Anatolian Journal of Cardiology | Q15716765 |
| P1476 | title | Long-term prognostic significance of pentraxin-3 in patients with acute myocardial infarction: 5-year prospective cohort study. | |
| P478 | volume | 17 |
| Q89834282 | Combining Novel Biomarkers for Risk Stratification of Two-Year Cardiovascular Mortality in Patients with ST-Elevation Myocardial Infarction |
| Q90364928 | Factors influencing left ventricular ejection fraction in patients with coronary microvascular disease and obstructive coronary artery disease |
| Q64996975 | Galectin 3 and Galectin 3 Binding Protein Improve the Risk Stratification after Myocardial Infarction. |
| Q61447273 | Inflammation-based Glasgow Prognostic Score in patients with acute ST-segment elevation myocardial infarction: A prospective cohort study |
| Q64105040 | Pentraxin 3 in Cardiovascular Disease |
| Q52761490 | Relationship between plasma pentraxin 3 level and risk of chronic kidney disease in the Korean elderly: the Dong-gu study. |
| Q89682116 | Relationship of activin A levels with clinical presentation, extent, and severity of coronary artery disease |
| Q64897646 | The Effect of Thyroid Stimulating Hormone Level Within the Reference Range on In-Hospital and Short-Term Prognosis in Acute Coronary Syndrome Patients. |
| Q64950491 | The Inflammation-Based Glasgow Prognostic Score as a Prognostic Factor in Patients with Intensive Cardiovascular Care Unit. |
| Q47626900 | Update on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases |
Search more.